Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT02777567
Eligibility Criteria:
Inclusion Criteria:
* 1\. Eligible for, or on active study drug treatment according to the approved label; patients with locally advanced or metastatic, EGFR T790M mutation-positive NSCLC, who have progressed on or after EGFR tyrosine kinase receptor (TKI) therapy
* 2\. Provision of signed and dated written informed consent by the patient or legally acceptable representative
Exclusion Criteria:
* 1\. History of hypersensitivity to excipients of the study drug or to drugs with a similar chemical structure or class to the study drug
* 2\. Pregnancy and/or breast feeding
* 3\. Current participation in any interventional trial
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02777567
Study Brief:
Protocol Section:
NCT02777567